QuidelOrtho Corporation (QDEL)
USD 42.46
(-1.32%)
USD 42.46
(-1.32%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.99 Billion USD | -8.34% |
| 2022 | 3.26 Billion USD | 92.28% |
| 2021 | 1.69 Billion USD | 2.22% |
| 2020 | 1.66 Billion USD | 210.66% |
| 2019 | 534.89 Million USD | 2.41% |
| 2018 | 522.28 Million USD | 88.05% |
| 2017 | 277.74 Million USD | 44.96% |
| 2016 | 191.6 Million USD | -2.31% |
| 2015 | 196.12 Million USD | 7.4% |
| 2014 | 182.61 Million USD | 4.11% |
| 2013 | 175.41 Million USD | 12.63% |
| 2012 | 155.74 Million USD | -1.8% |
| 2011 | 158.6 Million USD | 39.94% |
| 2010 | 113.33 Million USD | -31.01% |
| 2009 | 164.28 Million USD | 28.21% |
| 2008 | 128.13 Million USD | 8.53% |
| 2007 | 118.06 Million USD | 11.37% |
| 2006 | 106.01 Million USD | 14.86% |
| 2005 | 92.29 Million USD | 17.29% |
| 2004 | 78.69 Million USD | -17.26% |
| 2003 | 95.1 Million USD | 24.69% |
| 2002 | 76.27 Million USD | 3.0% |
| 2001 | 74.05 Million USD | 8.35% |
| 2000 | 68.35 Million USD | 0.0% |
| 1998 | 47.2 Million USD | 3.28% |
| 1997 | 45.7 Million USD | 9.07% |
| 1996 | 41.9 Million USD | 21.45% |
| 1995 | 34.5 Million USD | 10.93% |
| 1994 | 31.1 Million USD | 9.51% |
| 1993 | 28.4 Million USD | 2.53% |
| 1992 | 27.7 Million USD | 4.53% |
| 1991 | 26.5 Million USD | -4.68% |
| 1990 | 27.8 Million USD | 208.89% |
| 1989 | 9 Million USD | 3.45% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 709.7 Million USD | -4.43% |
| 2024 Q2 | 636.3 Million USD | -10.34% |
| 2023 Q2 | 665.1 Million USD | -21.39% |
| 2023 Q1 | 846.1 Million USD | -2.35% |
| 2023 FY | 2.99 Billion USD | -8.34% |
| 2023 Q3 | 744 Million USD | 11.86% |
| 2023 Q4 | 742.6 Million USD | -0.19% |
| 2022 FY | 3.26 Billion USD | 92.28% |
| 2022 Q1 | 1 Billion USD | 57.37% |
| 2022 Q2 | 613.4 Million USD | -38.8% |
| 2022 Q3 | 783.8 Million USD | 27.78% |
| 2022 Q4 | 866.5 Million USD | 10.55% |
| 2021 Q4 | 636.86 Million USD | 24.94% |
| 2021 FY | 1.69 Billion USD | 2.22% |
| 2021 Q2 | 176.61 Million USD | -52.95% |
| 2021 Q3 | 509.73 Million USD | 188.62% |
| 2021 Q1 | 375.33 Million USD | -53.62% |
| 2020 Q1 | 174.65 Million USD | 14.77% |
| 2020 Q4 | 809.2 Million USD | 69.98% |
| 2020 FY | 1.66 Billion USD | 210.66% |
| 2020 Q3 | 476.05 Million USD | 135.96% |
| 2020 Q2 | 201.75 Million USD | 15.52% |
| 2019 FY | 534.89 Million USD | 2.41% |
| 2019 Q2 | 108.25 Million USD | -26.84% |
| 2019 Q1 | 147.96 Million USD | 11.6% |
| 2019 Q4 | 152.17 Million USD | 20.31% |
| 2019 Q3 | 126.49 Million USD | 16.85% |
| 2018 FY | 522.28 Million USD | 88.05% |
| 2018 Q1 | 169.14 Million USD | 47.22% |
| 2018 Q3 | 117.39 Million USD | 13.81% |
| 2018 Q2 | 103.15 Million USD | -39.01% |
| 2018 Q4 | 132.58 Million USD | 12.94% |
| 2017 Q1 | 73.69 Million USD | 39.55% |
| 2017 FY | 277.74 Million USD | 44.96% |
| 2017 Q4 | 114.89 Million USD | 125.74% |
| 2017 Q3 | 50.89 Million USD | 33.0% |
| 2017 Q2 | 38.26 Million USD | -48.07% |
| 2016 Q3 | 49.34 Million USD | 26.09% |
| 2016 FY | 191.6 Million USD | -2.31% |
| 2016 Q4 | 52.8 Million USD | 7.03% |
| 2016 Q1 | 50.32 Million USD | -3.99% |
| 2016 Q2 | 39.13 Million USD | -22.23% |
| 2015 Q2 | 34.87 Million USD | -43.11% |
| 2015 FY | 196.12 Million USD | 7.4% |
| 2015 Q3 | 46.81 Million USD | 34.24% |
| 2015 Q1 | 61.3 Million USD | -3.61% |
| 2015 Q4 | 52.41 Million USD | 11.96% |
| 2014 Q4 | 63.59 Million USD | 55.66% |
| 2014 Q2 | 31.48 Million USD | -32.53% |
| 2014 Q1 | 46.67 Million USD | -6.97% |
| 2014 FY | 182.61 Million USD | 4.11% |
| 2014 Q3 | 40.85 Million USD | 29.75% |
| 2013 Q1 | 61.99 Million USD | 14.97% |
| 2013 Q3 | 33.53 Million USD | 12.9% |
| 2013 FY | 175.41 Million USD | 12.63% |
| 2013 Q4 | 50.17 Million USD | 49.59% |
| 2013 Q2 | 29.7 Million USD | -52.08% |
| 2012 Q3 | 32.99 Million USD | 6.93% |
| 2012 Q2 | 30.85 Million USD | -18.71% |
| 2012 Q1 | 37.96 Million USD | -1.12% |
| 2012 FY | 155.74 Million USD | -1.8% |
| 2012 Q4 | 53.92 Million USD | 63.42% |
| 2011 Q4 | 38.39 Million USD | 15.96% |
| 2011 Q1 | 59.59 Million USD | 87.94% |
| 2011 FY | 158.6 Million USD | 39.94% |
| 2011 Q2 | 27.5 Million USD | -53.84% |
| 2011 Q3 | 33.1 Million USD | 20.35% |
| 2010 Q1 | 28.37 Million USD | -57.39% |
| 2010 Q4 | 31.7 Million USD | 12.34% |
| 2010 Q3 | 28.22 Million USD | 12.78% |
| 2010 Q2 | 25.02 Million USD | -11.82% |
| 2010 FY | 113.33 Million USD | -31.01% |
| 2009 Q4 | 66.59 Million USD | 18.6% |
| 2009 Q2 | 24.64 Million USD | 45.9% |
| 2009 Q1 | 16.89 Million USD | -49.56% |
| 2009 Q3 | 56.15 Million USD | 127.86% |
| 2009 FY | 164.28 Million USD | 28.21% |
| 2008 Q1 | 40.86 Million USD | 7.59% |
| 2008 FY | 128.13 Million USD | 8.53% |
| 2008 Q4 | 33.48 Million USD | 5.07% |
| 2008 Q3 | 31.86 Million USD | 45.41% |
| 2008 Q2 | 21.91 Million USD | -46.37% |
| 2007 FY | 118.06 Million USD | 11.37% |
| 2007 Q2 | 18.58 Million USD | -45.25% |
| 2007 Q4 | 37.98 Million USD | 37.76% |
| 2007 Q3 | 27.57 Million USD | 48.39% |
| 2007 Q1 | 33.93 Million USD | -12.48% |
| 2006 FY | 106.01 Million USD | 14.86% |
| 2006 Q4 | 38.77 Million USD | 63.47% |
| 2006 Q3 | 23.72 Million USD | 44.01% |
| 2006 Q2 | 16.47 Million USD | -39.11% |
| 2006 Q1 | 27.05 Million USD | -22.22% |
| 2005 Q1 | 22.66 Million USD | -25.74% |
| 2005 Q4 | 34.77 Million USD | 73.61% |
| 2005 Q3 | 20.03 Million USD | 35.14% |
| 2005 Q2 | 14.82 Million USD | -34.6% |
| 2005 FY | 92.29 Million USD | 17.29% |
| 2004 Q1 | 19.73 Million USD | -40.58% |
| 2004 FY | 78.69 Million USD | -17.26% |
| 2004 Q2 | 14.28 Million USD | -27.63% |
| 2004 Q3 | 14.15 Million USD | -0.92% |
| 2004 Q4 | 30.52 Million USD | 115.69% |
| 2003 Q3 | 18.61 Million USD | -1.37% |
| 2003 Q4 | 33.21 Million USD | 78.38% |
| 2003 Q2 | 18.87 Million USD | -22.62% |
| 2003 Q1 | 24.39 Million USD | 7.16% |
| 2003 FY | 95.1 Million USD | 24.69% |
| 2002 FY | 76.27 Million USD | 3.0% |
| 2002 Q4 | 22.76 Million USD | 56.91% |
| 2002 Q1 | 21.21 Million USD | -1.58% |
| 2002 Q2 | 17.78 Million USD | -16.14% |
| 2002 Q3 | 14.5 Million USD | -18.44% |
| 2001 Q3 | 16.56 Million USD | 6.73% |
| 2001 Q4 | 21.55 Million USD | 30.09% |
| 2001 FY | 74.05 Million USD | 8.35% |
| 2001 Q1 | 19.54 Million USD | 3.66% |
| 2001 Q2 | 15.52 Million USD | -20.57% |
| 2000 Q3 | 10.46 Million USD | -38.31% |
| 2000 Q4 | 18.85 Million USD | 80.16% |
| 2000 Q1 | 22.06 Million USD | 0.0% |
| 2000 FY | 68.35 Million USD | 0.0% |
| 2000 Q2 | 16.96 Million USD | -23.13% |
| 1999 Q2 | 10.6 Million USD | 6.0% |
| 1999 Q1 | 10 Million USD | -32.89% |
| 1999 Q3 | 12.2 Million USD | 15.09% |
| 1998 FY | 47.2 Million USD | 3.28% |
| 1998 Q1 | 13.3 Million USD | 7.26% |
| 1998 Q2 | 9.8 Million USD | -26.32% |
| 1998 Q4 | 14.9 Million USD | 30.7% |
| 1998 Q3 | 11.4 Million USD | 16.33% |
| 1997 Q2 | 8.7 Million USD | -28.69% |
| 1997 Q4 | 12.4 Million USD | 3.33% |
| 1997 FY | 45.7 Million USD | 9.07% |
| 1997 Q1 | 12.2 Million USD | 4.27% |
| 1997 Q3 | 12 Million USD | 37.93% |
| 1996 FY | 41.9 Million USD | 21.45% |
| 1996 Q4 | 11.7 Million USD | 20.62% |
| 1996 Q3 | 9.7 Million USD | 7.78% |
| 1996 Q2 | 9 Million USD | 7.14% |
| 1996 Q1 | 8.4 Million USD | -9.68% |
| 1995 Q1 | 9.4 Million USD | 2.17% |
| 1995 Q2 | 8.5 Million USD | -9.57% |
| 1995 Q3 | 8.3 Million USD | -2.35% |
| 1995 Q4 | 9.3 Million USD | 12.05% |
| 1995 FY | 34.5 Million USD | 10.93% |
| 1994 FY | 31.1 Million USD | 9.51% |
| 1994 Q4 | 9.2 Million USD | 35.29% |
| 1994 Q3 | 6.8 Million USD | 28.3% |
| 1994 Q2 | 5.3 Million USD | -29.33% |
| 1994 Q1 | 7.5 Million USD | 0.0% |
| 1993 Q1 | 8.1 Million USD | 8.0% |
| 1993 Q4 | 7.5 Million USD | 13.64% |
| 1993 FY | 28.4 Million USD | 2.53% |
| 1993 Q3 | 6.6 Million USD | 0.0% |
| 1993 Q2 | 6.6 Million USD | -18.52% |
| 1992 Q4 | 7.5 Million USD | 10.29% |
| 1992 Q1 | 7.4 Million USD | 10.45% |
| 1992 Q2 | 5.6 Million USD | -24.32% |
| 1992 Q3 | 6.8 Million USD | 21.43% |
| 1992 FY | 27.7 Million USD | 4.53% |
| 1991 Q4 | 6.7 Million USD | 9.84% |
| 1991 Q1 | 7 Million USD | 0.0% |
| 1991 FY | 26.5 Million USD | -4.68% |
| 1991 Q2 | 6.9 Million USD | -1.43% |
| 1991 Q3 | 6.1 Million USD | -11.59% |
| 1990 Q2 | 6.9 Million USD | 176.0% |
| 1990 Q1 | 2.5 Million USD | 4.17% |
| 1990 Q4 | 7 Million USD | 1.45% |
| 1990 FY | 27.8 Million USD | 208.89% |
| 1990 Q3 | 6.9 Million USD | 0.0% |
| 1989 FY | 9 Million USD | 3.45% |
| 1989 Q1 | 2 Million USD | -13.04% |
| 1989 Q2 | 1.8 Million USD | -10.0% |
| 1989 Q4 | 2.4 Million USD | 4.35% |
| 1989 Q3 | 2.3 Million USD | 27.78% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -3002.253% |
| AngioDynamics, Inc. | 303.91 Million USD | -886.397% |
| AtriCure, Inc. | 399.24 Million USD | -650.867% |
| Avinger, Inc. | 7.65 Million USD | -39076.686% |
| Azenta, Inc. | 665.07 Million USD | -350.748% |
| BioLife Solutions, Inc. | 143.27 Million USD | -1992.398% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 16.57% |
| Daxor Corporation | 1.28 Million USD | -234008.933% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -16300.241% |
| Femasys Inc. | 1.07 Million USD | -279553.349% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -2570.646% |
| Hologic, Inc. | 4.03 Billion USD | 25.618% |
| ICU Medical, Inc. | 2.25 Billion USD | -32.697% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 57.92% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -10412.08% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | -1449.379% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -260017.538% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -260017.538% |
| Masimo Corporation | 2.04 Billion USD | -46.37% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -2987.367% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | -138.419% |
| Nephros, Inc. | 14.23 Million USD | -20954.923% |
| NovoCure Limited | 509.33 Million USD | -488.568% |
| NEXGEL, Inc. | 4.08 Million USD | -73213.769% |
| NEXGEL, Inc. | 4.08 Million USD | -73213.769% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -102881.793% |
| OraSure Technologies, Inc. | 405.47 Million USD | -639.336% |
| Pro-Dex, Inc. | 53.84 Million USD | -5467.566% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -168306.932% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -15591.714% |
| Repligen Corporation | 638.76 Million USD | -369.313% |
| Sanara MedTech Inc. | 64.98 Million USD | -4512.721% |
| STAAR Surgical Company | 322.41 Million USD | -829.795% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -5868.86% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 24.393% |
| Jin Medical International Ltd. | 19.82 Million USD | -15024.014% |